Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Because of the difference between medications, some patients who are switching from tirzepatide to semaglutide or vice versa may experience changes in appetite, side effects, or weight loss progress
Hier gibt es kein Optimum
Retatrutide (also identified by the compound code LY3437943) is an investigational peptide medicine being developed by Eli Lilly as a potential treatment for obesity and related metabolic conditions
Stays at the higher number through Month 3
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 27.57
US$ 28.82
US$ 23.48
US$ 28.73
US$ 27.06
US$ 29.37
US$ 27.98
US$ 27.74
US$ 24.85
